Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingmei Hsu

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|June 11, 2020
Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cellsAlexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, et al.
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Leukemia & Lymphoma|February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high riskKoen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic LeukemiaJingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Transplantation and Cellular Therapy|November 5, 2022
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab RecipientsChandni Patel, Michelle Pasciolla, Rachel Abramova, et al.
Transplantation and Cellular Therapy|June 1, 2022
Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell TransplantationFolashade Otegbeye, Marcelo A Fernandez Vina, Tao Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infectionsMohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, et al.
Nature Communications|September 18, 2024
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infectionsMohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, et al.
Cell|March 17, 2023
HIV-1 remission and possible cure in a woman after haplo-cord blood transplantJingmei Hsu, Koen Van Besien, Marshall J Glesby, et al.
Life Science Alliance|December 28, 2020
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|June 11, 2020
Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cellsAlexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, et al.
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Leukemia & Lymphoma|February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high riskKoen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic LeukemiaJingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Transplantation and Cellular Therapy|November 5, 2022
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab RecipientsChandni Patel, Michelle Pasciolla, Rachel Abramova, et al.
Transplantation and Cellular Therapy|June 1, 2022
Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell TransplantationFolashade Otegbeye, Marcelo A Fernandez Vina, Tao Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infectionsMohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, et al.
Nature Communications|September 18, 2024
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infectionsMohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, et al.
Cell|March 17, 2023
HIV-1 remission and possible cure in a woman after haplo-cord blood transplantJingmei Hsu, Koen Van Besien, Marshall J Glesby, et al.
Life Science Alliance|December 28, 2020
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Pageof 3